H.C. Wainwright Downgrades FibroGen (FGEN) to Neutral
Tweet
Share
E-mailGet Alerts FGEN Hot Sheet
Price: $9.71 --0%
Rating Summary:
4 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Rating Summary:
4 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Join SI Premium – FREE
H.C. Wainwright analyst Edwin Zhang downgraded FibroGen (NASDAQ: FGEN) from Buy to Neutral.
For an analyst ratings summary and ratings history on FibroGen click here. For more ratings news on FibroGen click here.
Shares of FibroGen closed at $25.90 yesterday.
You May Also Be Interested In
- Stifel Downgrades Weave Communications Inc (WEAV) to Hold
- Deutsche Bank Downgrades Oxford Biomedica (OXB:LN) (OXBDF) to Hold
- BofA Securities Downgrades Autohome Inc. (ATHM) to Underperform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
